Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Ribavirin + Peginterferon for HCV Genotype 1 Non-Responders/Relapsers
NCT00735969Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Aug 2008
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ribavirin in hepatitis C (HCV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Aug 2008; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00735969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735969.